Suppr超能文献

神经紊乱和干细胞作为一种疗法的潜在作用。

Neurological disorders and the potential role for stem cells as a therapy.

机构信息

Center of Excellence for Aging and Brain Repair, Department of Neurosurgery and Brain Repair, University of South Florida, Tampa, FL 33612, USA.

出版信息

Br Med Bull. 2012;101(1):163-81. doi: 10.1093/bmb/lds001. Epub 2012 Feb 21.

Abstract

Introduction Neurological disorders are routinely characterized by loss of cells in response to an injury or a progressive insult. Stem cells could therefore be useful to treat these disorders. Sources of data Pubmed searches of recent literature. Areas of agreement Stem cells exhibit proliferative capacity making them ideally suited for replacing dying cells. However, instead of cell replacement therapy stem cell transplants frequently appear to work via neurotrophic factor release, immunomodulation and upregulation of endogenous stem cells. Areas of controversy and areas timely for developing research Many questions remain with respect to the use of stem cells as a therapy, the answers to which will vary depending on the disorder to be treated and mode of action. Whereas the potential tumorigenic capability of stem cells is a concern, most studies do not support this notion. Further determination of the optimal cell type, and whether to perform allogeneic or autologous transplants warrant investigation before the full potential of stem cells can be realized. In addition, the use of stem cells to develop disease models should not be overlooked.

摘要

介绍

神经系统疾病通常表现为细胞因损伤或进行性损伤而死亡。因此,干细胞可能对治疗这些疾病有用。

数据来源

对近期文献的 Pubmed 检索。

意见一致

干细胞具有增殖能力,非常适合替代死亡细胞。然而,干细胞移植似乎更经常通过神经营养因子释放、免疫调节和上调内源性干细胞来发挥作用,而不是细胞替代疗法。

争议和需要研究的领域

对于将干细胞用作治疗方法,仍有许多问题有待解决,答案将因待治疗的疾病和作用模式而异。虽然干细胞的潜在致瘤能力是一个问题,但大多数研究并不支持这一观点。在充分发挥干细胞的潜力之前,还需要进一步确定最佳的细胞类型,以及是否进行同种异体或自体移植。此外,不应忽视使用干细胞来开发疾病模型。

相似文献

1
Neurological disorders and the potential role for stem cells as a therapy.
Br Med Bull. 2012;101(1):163-81. doi: 10.1093/bmb/lds001. Epub 2012 Feb 21.
2
Cell therapies for neurological disease--from bench to clinic to bench.
Expert Opin Biol Ther. 2005 Mar;5(3):289-91. doi: 10.1517/14712598.5.3.289.
3
Stem cells of the human cornea.
Br Med Bull. 2011;100:191-207. doi: 10.1093/bmb/ldr026. Epub 2011 Jun 16.
4
Cell-based therapies for lung disease.
Br Med Bull. 2012;101(1):147-61. doi: 10.1093/bmb/ldr051. Epub 2012 Jan 25.
5
Stem cells and neurological diseases.
Cell Prolif. 2008 Feb;41 Suppl 1(Suppl 1):94-114. doi: 10.1111/j.1365-2184.2008.00486.x.
6
Stem cell therapy for neurological disorders.
S Afr Med J. 2019 Sep 10;109(8b):70-77. doi: 10.7196/SAMJ.2019.v109i8b.14009.
7
The potential of stem cell therapies for neurological diseases.
Expert Rev Neurother. 2006 Feb;6(2):153-61. doi: 10.1586/14737175.6.2.153.
8
Intranasal delivery of stem cells to the brain.
Expert Opin Drug Deliv. 2011 May;8(5):623-32. doi: 10.1517/17425247.2011.566267. Epub 2011 Mar 19.
9
Cell therapy for neurological disorders.
Nat Med. 2024 Oct;30(10):2756-2770. doi: 10.1038/s41591-024-03281-3. Epub 2024 Oct 15.
10
Stem cells as a potential treatment of neurological disorders.
Curr Opin Pharmacol. 2004 Feb;4(1):98-104. doi: 10.1016/j.coph.2003.09.006.

引用本文的文献

3
Cell Transplantation to Restore Lost Auditory Nerve Function is a Realistic Clinical Opportunity.
Cell Transplant. 2021 Jan-Dec;30:9636897211035076. doi: 10.1177/09636897211035076.
6
Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke.
Transl Stroke Res. 2015 Dec;6(6):421-9. doi: 10.1007/s12975-015-0430-x.
7
Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells.
Expert Rev Neurother. 2015 Oct;15(10):1231-40. doi: 10.1586/14737175.2015.1091727. Epub 2015 Sep 22.
8
Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke.
Stroke. 2015 Sep;46(9):2616-27. doi: 10.1161/STROKEAHA.115.009854. Epub 2015 Jul 28.
9
Improvements in biomaterial matrices for neural precursor cell transplantation.
Mol Cell Ther. 2014 Jul 1;2:19. doi: 10.1186/2052-8426-2-19. eCollection 2014.
10
An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside.
J Clin Med. 2013 Dec;2(4):220-241. doi: 10.3390/jcm2040220.

本文引用的文献

2
Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells.
Histochem Cell Biol. 2011 Oct;136(4):455-73. doi: 10.1007/s00418-011-0858-3. Epub 2011 Aug 31.
4
Human stem cell research and regenerative medicine--present and future.
Br Med Bull. 2011;99:155-68. doi: 10.1093/bmb/ldr027. Epub 2011 Jun 13.
5
Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke.
Neurosci Biobehav Rev. 2012 Jan;36(1):177-90. doi: 10.1016/j.neubiorev.2011.05.010. Epub 2011 May 27.
6
Immunogenicity of induced pluripotent stem cells.
Nature. 2011 May 13;474(7350):212-5. doi: 10.1038/nature10135.
7
Intranasal delivery of stem cells to the brain.
Expert Opin Drug Deliv. 2011 May;8(5):623-32. doi: 10.1517/17425247.2011.566267. Epub 2011 Mar 19.
8
Stem cells: The dark side of induced pluripotency.
Nature. 2011 Mar 3;471(7336):46-7. doi: 10.1038/471046a.
9
Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.
Cell Med. 2010 Jan 1;1(1):15-46. doi: 10.3727/215517910X516673.
10
ReNeuron and StemCells get green light for neural stem cell trials.
Nat Biotechnol. 2011 Feb;29(2):95-7. doi: 10.1038/nbt0211-95.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验